TWM477925U - Sample extraction device and kit - Google Patents
Sample extraction device and kit Download PDFInfo
- Publication number
- TWM477925U TWM477925U TW103200029U TW103200029U TWM477925U TW M477925 U TWM477925 U TW M477925U TW 103200029 U TW103200029 U TW 103200029U TW 103200029 U TW103200029 U TW 103200029U TW M477925 U TWM477925 U TW M477925U
- Authority
- TW
- Taiwan
- Prior art keywords
- buffer
- accommodating
- column
- upper portion
- tube
- Prior art date
Links
- 238000000605 extraction Methods 0.000 title claims description 83
- 239000012528 membrane Substances 0.000 claims description 148
- 239000007788 liquid Substances 0.000 claims description 63
- 239000000872 buffer Substances 0.000 claims description 61
- 238000010438 heat treatment Methods 0.000 claims description 29
- 239000000243 solution Substances 0.000 claims description 29
- 239000012530 fluid Substances 0.000 claims description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 20
- 239000000463 material Substances 0.000 claims description 15
- 239000011534 wash buffer Substances 0.000 claims description 9
- 239000012149 elution buffer Substances 0.000 claims description 8
- 239000003960 organic solvent Substances 0.000 claims description 6
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 206010057248 Cell death Diseases 0.000 claims description 4
- 230000009089 cytolysis Effects 0.000 claims description 4
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 claims description 3
- 229910052782 aluminium Inorganic materials 0.000 claims description 3
- 239000012148 binding buffer Substances 0.000 claims description 3
- 239000011888 foil Substances 0.000 claims description 3
- 239000007789 gas Substances 0.000 claims description 2
- 238000007789 sealing Methods 0.000 claims description 2
- 238000003032 molecular docking Methods 0.000 claims 1
- 238000000935 solvent evaporation Methods 0.000 claims 1
- 238000000746 purification Methods 0.000 description 172
- 108020004707 nucleic acids Proteins 0.000 description 90
- 102000039446 nucleic acids Human genes 0.000 description 90
- 150000007523 nucleic acids Chemical class 0.000 description 90
- 239000000523 sample Substances 0.000 description 82
- 238000000034 method Methods 0.000 description 55
- 230000000052 comparative effect Effects 0.000 description 51
- 238000004140 cleaning Methods 0.000 description 45
- 239000002699 waste material Substances 0.000 description 19
- 239000000047 product Substances 0.000 description 14
- 238000005119 centrifugation Methods 0.000 description 11
- 238000009739 binding Methods 0.000 description 9
- 239000011148 porous material Substances 0.000 description 9
- 238000005406 washing Methods 0.000 description 8
- 239000007864 aqueous solution Substances 0.000 description 6
- 230000002209 hydrophobic effect Effects 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000011344 liquid material Substances 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 5
- 229920002301 cellulose acetate Polymers 0.000 description 5
- 239000003153 chemical reaction reagent Substances 0.000 description 5
- 238000012545 processing Methods 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 108091092584 GDNA Proteins 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- -1 Polypropylene Polymers 0.000 description 3
- 230000004308 accommodation Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 239000013592 cell lysate Substances 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 238000011109 contamination Methods 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- 239000000020 Nitrocellulose Substances 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 239000002152 aqueous-organic solution Substances 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 229910000420 cerium oxide Inorganic materials 0.000 description 2
- 239000012295 chemical reaction liquid Substances 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 229920001220 nitrocellulos Polymers 0.000 description 2
- BMMGVYCKOGBVEV-UHFFFAOYSA-N oxo(oxoceriooxy)cerium Chemical compound [Ce]=O.O=[Ce]=O BMMGVYCKOGBVEV-UHFFFAOYSA-N 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 2
- 238000000638 solvent extraction Methods 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 239000010902 straw Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-M Acrylate Chemical compound [O-]C(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-M 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 239000007993 MOPS buffer Substances 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000002033 PVDF binder Substances 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920002845 Poly(methacrylic acid) Polymers 0.000 description 1
- 239000004721 Polyphenylene oxide Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 238000012864 cross contamination Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000005611 electricity Effects 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000003365 glass fiber Substances 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910010272 inorganic material Inorganic materials 0.000 description 1
- 239000011147 inorganic material Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000012139 lysis buffer Substances 0.000 description 1
- UEGPKNKPLBYCNK-UHFFFAOYSA-L magnesium acetate Chemical compound [Mg+2].CC([O-])=O.CC([O-])=O UEGPKNKPLBYCNK-UHFFFAOYSA-L 0.000 description 1
- 235000011285 magnesium acetate Nutrition 0.000 description 1
- 239000011654 magnesium acetate Substances 0.000 description 1
- 229940069446 magnesium acetate Drugs 0.000 description 1
- 238000007886 magnetic bead extraction Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000001821 nucleic acid purification Methods 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 229920000620 organic polymer Polymers 0.000 description 1
- 150000002923 oximes Chemical class 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004584 polyacrylic acid Substances 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920000570 polyether Polymers 0.000 description 1
- 229920002338 polyhydroxyethylmethacrylate Polymers 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 229920000915 polyvinyl chloride Polymers 0.000 description 1
- 239000004800 polyvinyl chloride Substances 0.000 description 1
- 229920002981 polyvinylidene fluoride Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- KCXFHTAICRTXLI-UHFFFAOYSA-N propane-1-sulfonic acid Chemical compound CCCS(O)(=O)=O KCXFHTAICRTXLI-UHFFFAOYSA-N 0.000 description 1
- 238000005086 pumping Methods 0.000 description 1
- 239000012521 purified sample Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
Landscapes
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Description
本創作有關一種萃取裝置,特別是關於一種樣品萃取裝置、其吸取部件、流體控制裝置、及容置套組。The present invention relates to an extraction device, and more particularly to a sample extraction device, a suction member, a fluid control device, and a housing set.
隨著生物科技的發展以及遺傳物質的解碼,越來越多的生物相關實驗室或醫院甚至法醫檢驗等等,皆頻繁的使用抽取檢體內的核酸來進行實驗或檢查。抽取並純化核酸的方法很多,而目前最常見的方法分成三類:管柱萃取法、磁珠萃取法以及試劑萃取法,而試劑萃取法又分成兩類,分別是有機溶劑萃取法和非有機溶劑萃取法。各種萃取方法皆有其優缺點,然而,管柱萃取法是目前操作上最安全簡便且效果最佳的方式。With the development of biotechnology and the decoding of genetic material, more and more biologically relevant laboratories or hospitals and even forensic tests, etc., frequently use the nucleic acids in the sample to conduct experiments or inspections. There are many methods for extracting and purifying nucleic acids. At present, the most common methods are divided into three categories: column extraction, magnetic bead extraction and reagent extraction. The reagent extraction method is divided into two categories, organic solvent extraction and non-organic. Solvent extraction method. Various extraction methods have their advantages and disadvantages. However, the column extraction method is the safest, simplest and most effective way to operate.
而利用該管柱萃取法的萃取流程又可分成兩種,一種是管柱離心萃取法,另一種則為管柱真空萃取法。第1圖為習知的管柱離心萃取法,首先,裝於微量離心管10內的處理過的檢體(如利用陰離子清潔劑將細胞打破釋放出核酸,並使蛋白質變性)轉置於一純化管20中,該純化管20通常可分成三部分,上頸部201、中間管體部202,以及下尖部204;中間管體部202的底部具有純化膜203,而下尖部204則具通道可使液體流出,通常檢體是利用微量分注器(pipette)將微量離心管10內的檢體吸取後,由純化管20的上方注入至純化管20中。純化管20外套有一廢液管30,將套合而為一體 的雙管置於離心機中離心,由於核酸帶負電,會與帶正電的純化膜203結合而吸附於其上,而其它雜質則會因為離心力的關係而穿透純化膜203且通過純化管20的下尖部的通道而流到廢液管30內,此步驟稱為「結合步驟」;接著,於純化管20內加入清洗液後再次離心,使純化膜203上的雜質被離心出來提高核酸的純度,此步驟稱為「清洗步驟」;最後,將純化膜203上帶有核酸的純化管20轉置到收集管40中,加入特殊鹽度及pH值的沖提液改變純化膜203的電性,並再度離心,使核酸與純化膜203分離而流出,收集核酸於收集管40中,此步驟稱為「收集步驟」。管柱離心萃取法需要經過至少三次的離心,過程較為繁複且萃取時間會因等候離心而拉長。雖然市面上已有自動化的管柱離心萃取機台,但由於機台內必須設有離心設備,因此機台通常體積較大,且其萃取較為耗時的缺點並未克服。The extraction process using the column extraction method can be further divided into two types, one is a column centrifugal extraction method, and the other is a column vacuum extraction method. Figure 1 is a conventional column-centrifugal extraction method. First, the treated sample contained in the microcentrifuge tube 10 (such as breaking the cell with an anionic detergent to release the nucleic acid and denaturation of the protein) is transferred to a In the purification tube 20, the purification tube 20 can be generally divided into three parts, an upper neck portion 201, an intermediate tube portion 202, and a lower tip portion 204; the bottom portion of the intermediate tube portion 202 has a purification membrane 203, and the lower tip portion 204 has The passage of the passage allows the liquid to flow out. Usually, the sample is sucked from the sample in the microcentrifuge tube 10 by a pipette, and then injected into the purification tube 20 from above the purification tube 20. The purification tube 20 is jacketed with a waste liquid pipe 30, which is integrated into one body. The double tube is centrifuged in a centrifuge. Since the nucleic acid is negatively charged, it is bound to the positively charged purification membrane 203 and adsorbed thereon, while other impurities penetrate the purification membrane 203 and pass through the purification tube due to the centrifugal force. The passage of the lower tip portion of 20 flows into the waste liquid pipe 30. This step is referred to as a "binding step". Next, the cleaning liquid is added to the purification tube 20 and then centrifuged again to cause the impurities on the purification membrane 203 to be centrifuged to increase. The purity of the nucleic acid, this step is referred to as a "cleaning step"; finally, the purification tube 20 carrying the nucleic acid on the purified membrane 203 is transposed into the collection tube 40, and the purified membrane 203 is changed by adding a specific salinity and pH. The electrical properties are repeated again, and the nucleic acid is separated from the purification membrane 203 to flow out, and the nucleic acid is collected in the collection tube 40. This step is called a "collection step." Column centrifugation requires centrifugation at least three times, the process is complicated and the extraction time is elongated by waiting for centrifugation. Although there is an automated column centrifugal extraction machine on the market, since the centrifugal equipment must be provided in the machine, the machine is usually large in size, and the shortcomings of its extraction are not overcome.
另外一種管柱真空萃取法如第2圖所示,其原理也與管柱離心萃取法雷同,只是其「結合步驟」以及「清洗步驟」的步驟是用真空吸引取代離心方式,其係直接將純化管20插入壓力盒50中,利用氣體壓力,給予負壓使液體流出純化管20而直接進入液體收集瓶(未圖示),但是在最後的「收集步驟」仍然必須利用離心方式將核酸收集至收集管40中。因此,即便是自動化機台,也必須要有離心設備設置於其中。Another type of column vacuum extraction method is shown in Figure 2, and the principle is similar to the column centrifugal extraction method, except that the steps of "combination step" and "cleaning step" are to use vacuum suction instead of centrifugation, which will directly The purification tube 20 is inserted into the pressure cell 50, and the negative pressure is applied by the gas pressure to cause the liquid to flow out of the purification tube 20 and directly enter the liquid collection bottle (not shown), but in the final "collection step", the nucleic acid must be collected by centrifugation. To the collection tube 40. Therefore, even for an automated machine, a centrifugal device must be placed in it.
綜上所述,目前市面上雖然已有許多廠商研發出各種的管柱萃取套組及自動化機台,但其原理及萃取流程皆與上述之習知技術雷同,其存在的體積大且耗時較久的缺陷尚未被克服,因此,本技術領域中尚需一種新的方式及機台來克服這些缺點。In summary, although many manufacturers have developed various column extraction sets and automated machines on the market, the principle and extraction process are similar to the above-mentioned prior art, and their existence is large and time consuming. Longer deficiencies have not been overcome, and therefore there is a need in the art for a new way and machine to overcome these shortcomings.
為了解決上述萃取核酸所產生耗時且耗費人力的問題,以及自動化機台體積過大等的缺陷,本創作人出人意料地發想,利用習知的純化管,直接在純化管中利用氣壓的方式,完全僅利用純化管的下端抽吸及排放檢體、清洗液、沖提液等,完全不需要利用離心機,且不需要從純化管上頸部處注入檢體、清洗液或沖提液,即可有效地萃取核酸。因此,本創作人提供了一種氣壓式抽取核酸的裝置。In order to solve the problem that the above-mentioned extraction of nucleic acid is time-consuming and labor-intensive, and the size of the automated machine is too large, the creator unexpectedly imagines that the conventional purification tube can be used to directly use the air pressure in the purification tube. It only uses the lower end of the purification tube to pump and discharge the sample, the cleaning solution, the extract, etc., and does not need to use the centrifuge at all, and does not need to inject the sample, the cleaning solution or the extract from the neck of the purification tube. The nucleic acid can be efficiently extracted. Therefore, the present inventors have provided a device for pneumatically extracting nucleic acids.
在一實施態樣中,提供一種配合管柱部件所使用的吸取部件,包含:第一上部、連通於該第一上部下方且內徑小於該第一上部之內徑的中間部、及連通於該中間部下方且內徑小於該中間部之內徑的吸取部,藉此該第一上部或該中間部配合抵接該管柱部件之外周,且經由該吸取部將特定液體吸至該管柱部件。In one embodiment, a suction member for use in a tubular member is provided, comprising: a first upper portion, an intermediate portion communicating below the first upper portion and having an inner diameter smaller than an inner diameter of the first upper portion, and communicating with a suction portion below the intermediate portion and having an inner diameter smaller than an inner diameter of the intermediate portion, whereby the first upper portion or the intermediate portion is fitted against an outer circumference of the column member, and a specific liquid is sucked into the tube via the suction portion Column component.
再者,其中該第一上部之外圍具有呈現放射狀的複數個肋材,藉此當該吸取部件藉由該複數個肋材受到支持時,氣體可經由該複數個肋材彼此之間的間隙流動。Furthermore, wherein the periphery of the first upper portion has a plurality of ribs that are radially present, whereby when the suction member is supported by the plurality of ribs, gas can pass through the gap between the plurality of ribs flow.
在另一實施態樣中,提供一種樣品萃取裝置,包含前述之吸取部件,更包含:管柱部件,具有第二上部、第二下部、夾於該第二上部及該第二下部之間且與該第二上部及該第二下部連通的第二長柱部、及位於該第二長柱部之內的半透膜,以便使預期材料脫離樣品留置於該半透膜上;及應接部件,具有第三上部、第三下部、夾於該第三上部及該第三下部之間且與該第三上部及該第三下部連通的第三長柱部、及位於該第三長柱部之內的濾膜,藉此該第三上部及該第三長柱部配合抵接該管柱部件之該第二上部或該第二長柱部之內周,且藉由該濾膜防止特定液體由該第三 下部朝該第三上部過度流溢。In another embodiment, a sample extraction device is provided, comprising the suction member, further comprising: a tubular member having a second upper portion, a second lower portion, and being sandwiched between the second upper portion and the second lower portion a second long post portion communicating with the second upper portion and the second lower portion, and a semipermeable membrane positioned within the second long post portion to leave the desired material out of the sample on the semipermeable membrane; a third upper portion, a third lower portion, a third long column portion sandwiched between the third upper portion and the third lower portion and communicating with the third upper portion and the third lower portion, and the third long column a filter film in the portion, whereby the third upper portion and the third long column portion cooperate to abut the inner circumference of the second upper portion or the second long post portion of the column member, and are prevented by the filter film Specific liquid by the third The lower portion overflows excessively toward the third upper portion.
再者,其中該吸取部件之該第一上部具有呈現放射狀的複數個肋材,藉此當該吸取部件藉由該複數個肋材受到支持時,氣體可經由該複數個肋材彼此之間的間隙流動。Furthermore, wherein the first upper portion of the suction member has a plurality of ribs that are radially present, whereby when the suction member is supported by the plurality of ribs, gas can pass between the plurality of ribs The gap flows.
再者,其中該管柱部件更具有延伸自該第二上部的蓋部及設置於該半透膜上方的O環,該蓋部係用以密封該第二上部之開口,該O環係用以固定該半透膜。Furthermore, the column member further has a cover portion extending from the second upper portion and an O-ring disposed above the semi-permeable membrane, the cover portion sealing the opening of the second upper portion, the O-ring system To fix the semipermeable membrane.
再者,其中該應接部件之該第三長柱部具有刻紋,用以夾持該濾膜,且該第三上部之內徑大於該第三長柱部之內徑,該第三長柱部之內徑大於該第三下部之內徑,藉此該第三下部及該第三長柱部配合抵接該管柱部件之該第二上部或該第二長柱部之內周。Furthermore, the third long column portion of the connecting member has a knurling for clamping the filter film, and an inner diameter of the third upper portion is larger than an inner diameter of the third long column portion, the third length The inner diameter of the column portion is larger than the inner diameter of the third lower portion, whereby the third lower portion and the third long column portion cooperate to abut the inner circumference of the second upper portion or the second long column portion of the column member.
在另一實施態樣中,提供一種配合前述之吸取部件而使用的流體控制裝置,包含:管體、設置於該管體內的推桿、及連通於該管體下方的應接部件,其中該應接部件具有第三上部、第三下部、及夾於該第三上部及該第三下部之間且與該第三上部及該第三下部連通的第三長柱部,藉此該第三下部及該第三長柱部配合抵接該管柱部件之該第二上部或該長柱部之內周。In another embodiment, a fluid control device for use with the suction member described above is provided, comprising: a tubular body, a push rod disposed in the tubular body, and an attachment member connected to the lower portion of the tubular body, wherein the The connecting member has a third upper portion, a third lower portion, and a third long column portion sandwiched between the third upper portion and the third lower portion and communicating with the third upper portion and the third lower portion, whereby the third portion The lower portion and the third long column portion cooperate to abut the inner portion of the second upper portion or the long column portion of the column member.
再者,其中該應接部件的該第三上部之內徑大於該第三長柱部之內徑,該第三長柱部之內徑大於該第三下部之內徑,藉此該第三下部及該第三長柱部配合抵接該管柱部件之該第二上部或該第二長柱部之內周。Furthermore, the inner diameter of the third upper portion of the connecting member is larger than the inner diameter of the third long column portion, and the inner diameter of the third long column portion is larger than the inner diameter of the third lower portion, thereby the third The lower portion and the third long column portion cooperate to abut the inner circumference of the second upper portion or the second long column portion of the column member.
在又一實施態樣中,提供一種配合前述之樣品萃取裝置而使 用的容置套組,包含:應接部件容置部、鄰接該應接部件容置部的管柱部件容置部、鄰接該管柱部件容置部的吸取部件容置部、鄰接該吸取部件容置部的一或更多加熱套管、及鄰接該一或更多加熱套管或該吸取部件容置部且容置特定緩衝液的一或更多緩衝液套管,藉此使得依序容置於對應容置部的該應接部件、該管柱部件、及該吸取部件依序組裝並依序於該一或更多緩衝液套管或該一或更多加熱套管中進行對應萃取相關動作。In still another embodiment, a sample extraction device is provided in combination with the foregoing The accommodating set includes: a component receiving portion, a column member accommodating portion adjacent to the accommodating member accommodating portion, and a suction member accommodating portion adjacent to the column member accommodating portion, adjacent to the suction One or more heating sleeves of the component receiving portion, and one or more buffer sleeves adjacent to the one or more heating sleeves or the suction member receiving portion and accommodating a specific buffer, thereby The component that is placed in the corresponding accommodating portion, the column member, and the suction member are sequentially assembled and sequentially carried out in the one or more buffer sleeves or the one or more heating sleeves. Corresponding to extraction related actions.
再者,其中該一或更多加熱套管或該一或更多緩衝液套管之高度略大於該吸取部件之該中間部加該吸取部之高度,藉此避免無法吸取該一或更多加熱套管或該一或更多緩衝液套管中的液體。Furthermore, the height of the one or more heating sleeves or the one or more buffer sleeves is slightly larger than the height of the intermediate portion of the suction member plus the suction portion, thereby avoiding the inability to absorb the one or more Heating the liquid in the cannula or the one or more buffer sleeves.
再者,其中該一或更多緩衝液套管上附有鋁箔,並分別容置酵素、胞溶緩衝液、鍵結緩衝液、預洗緩衝液、沖洗緩衝液、後洗緩衝液、或洗提緩衝液,以便依序進行對應萃取相關動作。Furthermore, the one or more buffer sleeves are provided with aluminum foil, and respectively accommodate enzyme, cytolysis buffer, bonding buffer, prewash buffer, rinse buffer, post wash buffer, or wash. The buffer is extracted to perform the corresponding extraction-related actions in sequence.
再者,其中該一或更多緩衝液套管其中之若干套管僅容置空氣,以便揮發萃取殘留之有機溶劑。Furthermore, wherein some of the one or more buffer sleeves contain only air to volatilize the residual organic solvent.
再者,其中該一或更多加熱套管係分隔設置,以便分別加熱,提高加熱效率,加快有機溶劑揮發速率。Furthermore, wherein the one or more heating sleeves are arranged separately to be separately heated to increase the heating efficiency and accelerate the evaporation rate of the organic solvent.
再者,其中該應接部件容置部、該管柱部件容置部、或該吸取部件容置部分別具有不同大小的圓形開口,以便容置對應的應接部件、管柱部件、或吸取部件。Furthermore, the receiving part receiving portion, the column member receiving portion, or the suction member receiving portion respectively have circular openings of different sizes to accommodate corresponding connecting members, column members, or Pipette parts.
再者,其中該管柱部件容置部更包含長形開口,以便容置該管柱部件之蓋部。Furthermore, the column component receiving portion further includes an elongated opening for receiving the cover portion of the column member.
10‧‧‧微量離心管10‧‧‧Microcentrifuge tube
100‧‧‧檢體套管100‧‧‧Inspector casing
110‧‧‧產物套管110‧‧‧Product casing
120‧‧‧緩衝液套管120‧‧‧buffer casing
150‧‧‧容置套組150‧‧‧ accommodating kit
152‧‧‧應接部件容置部152‧‧‧ Should be connected to the component housing
154‧‧‧管柱部件容置部154‧‧‧Pipe component storage
156‧‧‧吸取部件容置部156‧‧‧Sucking parts accommodation
158‧‧‧加熱套管158‧‧‧heating casing
20‧‧‧純化管20‧‧‧purification tube
201‧‧‧上頸部201‧‧‧ upper neck
202‧‧‧中間管體部202‧‧‧Intermediate body
203‧‧‧純化膜203‧‧‧Purified membrane
204‧‧‧下尖部204‧‧‧The tip
205‧‧‧蓋部205‧‧‧ 盖部
206‧‧‧O環206‧‧O ring
30‧‧‧廢液管30‧‧‧Waste tube
40‧‧‧收集管40‧‧‧ Collection tube
50‧‧‧壓力盒50‧‧‧pressure box
60‧‧‧壓力設備60‧‧‧pressure equipment
70‧‧‧流體控制裝置70‧‧‧Fluid control device
701‧‧‧管體701‧‧‧ tube body
702‧‧‧推桿702‧‧‧Put
703‧‧‧針頭組件703‧‧‧Needle assembly
80‧‧‧移液吸管80‧‧‧ pipetting straw
802‧‧‧第一上部802‧‧‧ first upper
804‧‧‧中間部804‧‧‧ middle part
806‧‧‧吸取部806‧‧‧Drawing Department
808‧‧‧肋材808‧‧‧ ribs
90‧‧‧轉接頭90‧‧‧Adapter
901‧‧‧濾膜901‧‧‧ filter
902‧‧‧第三上部902‧‧‧ third upper
904‧‧‧第三長柱部904‧‧‧The third long column
906‧‧‧第三下部906‧‧ Third lower part
908‧‧‧刻紋908‧‧·grain
第1圖顯示習知之管柱離心萃取法萃取核酸流程圖。Figure 1 shows a flow chart for the extraction of nucleic acids by conventional column-column extraction.
第2圖顯示習知之管柱真空萃取法萃取核酸流程圖。Figure 2 shows a flow chart for extracting nucleic acids by conventional column vacuum extraction.
第3圖為本創作之氣壓式萃取核酸裝置之一實施例示意圖。Fig. 3 is a schematic view showing an embodiment of the pneumatic pressure extraction nucleic acid device of the present invention.
第4圖為本創作之氣壓式萃取核酸裝置之另一實施例示意圖。Fig. 4 is a schematic view showing another embodiment of the pneumatic pressure extraction nucleic acid device of the present invention.
第5圖為本創作之一實施例的流體控制裝置示意圖。Figure 5 is a schematic view of a fluid control device of one embodiment of the present invention.
第6圖為本創作之另一實施例的流體控制裝置示意圖。Figure 6 is a schematic view of a fluid control device of another embodiment of the present invention.
第7圖為本創作之氣壓式萃取核酸之自動化機台中所使用之容置套組示意圖。Figure 7 is a schematic diagram of the accommodating set used in the automated machine for the pneumatic extraction of nucleic acids.
第8圖為本創作之一實施例中配合樣品萃取裝置而使用的容置套組示意圖。Figure 8 is a schematic view of a housing kit used in conjunction with a sample extraction device in one embodiment of the present invention.
本文中術語「一」及「一種」代表於本文中之語法對象有一個或多於一個(即至少一個)。The terms "a" and "an" are used herein to mean one or more than one (ie, at least one) of the grammatical objects herein.
本文中術語「管柱部件」,或稱「純化管」,係為技術領域中習知之用於純化核酸之管柱,通常而言其包含一上頸部(於本文中又稱「第二上部」)、一中間管體部(於本文中又稱「第二長柱部」)、一半透膜以及一下尖部(於本文中又稱「第二下部」),該下尖部具有一通孔而可用於排出液體,但本創作中之該純化管並不限於此結構,只要該純化管為具有半透膜之通孔管體即在本創作之範圍內,管體的材料可為塑料如聚丙烯、聚苯乙醯、聚碳酸酯或聚氯乙烯等,或生物可降解性材料。該半透膜亦已為技術領域中所習知,該材質可為二氧化矽,表面電荷帶有正電,可與檢體中 帶負電的核酸電性結合,並受沖提液改變其電性後,釋放核酸;於本文中,該「半透膜」又稱「純化膜」,為可使溶液由其內部通過,亦即,當在與半透膜的一面接觸的空間與該半透膜的另一面空間之間存有壓力差時,溶液可由高壓空間往低壓空間流動而穿透該半透膜;或者,當該半透膜受到離心力時,溶液可沿著離心力的方向穿透該半透膜,但核酸則與該半透膜作用而吸附於該膜上;而本創作中所使用的半透膜透過該膜與核酸之間的相互作用來吸附核酸,其中,核酸與半透膜是透過極性或電性而互相吸引,於本創作之較佳實施例中,該半透膜為具有親水性基團之多孔膜(又稱親水性膜),且推測核酸之親水性基團與半透膜之親水性基團透過改變周圍的極性而互相吸引;本文中所稱之具有親水性基團之半透膜是指構成多孔膜材料本身具有親水性基團(如聚丙烯酸羥乙酯、聚甲基丙烯酸羥乙酯、聚乙烯醇、聚乙烯吡咯烷酮、聚丙烯酸、聚甲基丙烯酸、聚氧乙烯、醋酸纖維素、醋酸纖維素皂化物、醋酸纖維素混合物等,優選可使用具有羥基的有機聚合物),或者是對構成多孔膜的材料進行處理或塗敷,從而引進親水性基團,而任意的有機或無機材料均適合做為該多孔膜的材料,也可以是多種多孔膜的組合;所述之多孔膜中,為了能使溶液由內部通過,因此該膜的孔徑優選為大於或等於0.2μm,厚度優選為10μm至500μm,更佳為50μm至250μm。又本文中,純化管之上端及下端的定義為,一般的純化管結構中,較靠近該純化膜位置者為下端,而遠離該純化膜位置者為上端,但本創作並不限於此,而係以與壓力設備接合處者稱為純化管之上端,而用於吸取液體者稱為純化管之下端。The term "column component" or "purification tube" as used herein is a column of the art for purifying nucleic acids, which generally comprises an upper neck (also referred to herein as "the second upper portion". ""), an intermediate tube body (also referred to herein as "second long column portion"), a semi-permeable membrane and a lower tip (also referred to herein as "second lower portion") having a through hole It can be used to discharge liquid, but the purification tube in the present invention is not limited to this structure, as long as the purification tube is a through-hole tube having a semi-permeable membrane, that is, within the scope of the present invention, the material of the tube body may be plastic such as Polypropylene, polystyrene, polycarbonate or polyvinyl chloride, or biodegradable materials. The semipermeable membrane is also known in the art, and the material can be cerium oxide, and the surface charge is positively charged, and can be combined with the sample. The negatively charged nucleic acid is electrically coupled and is subjected to the electrical properties of the extracting liquid to release the nucleic acid; in the present invention, the "semipermeable membrane" is also referred to as "purified membrane", so that the solution can be passed through the interior thereof, that is, When there is a pressure difference between the space in contact with one side of the semipermeable membrane and the other surface of the semipermeable membrane, the solution may flow from the high pressure space to the low pressure space to penetrate the semipermeable membrane; or, when the half When the membrane is subjected to centrifugal force, the solution can penetrate the semipermeable membrane in the direction of centrifugal force, but the nucleic acid acts on the membrane with the semipermeable membrane; and the semipermeable membrane used in the present invention passes through the membrane and The interaction between nucleic acids to adsorb nucleic acids, wherein the nucleic acid and the semipermeable membrane are mutually attracted by polarity or electrical properties. In a preferred embodiment of the present invention, the semipermeable membrane is a porous membrane having a hydrophilic group. (also known as hydrophilic membrane), and it is presumed that the hydrophilic group of the nucleic acid and the hydrophilic group of the semipermeable membrane attract each other by changing the polarity of the surrounding; the semipermeable membrane having a hydrophilic group as referred to herein means The porous membrane material itself has a hydrophilic group ( Polyhydroxyethyl acrylate, polyhydroxyethyl methacrylate, polyvinyl alcohol, polyvinylpyrrolidone, polyacrylic acid, polymethacrylic acid, polyoxyethylene, cellulose acetate, cellulose acetate saponified, cellulose acetate mixture, etc. It is preferable to use an organic polymer having a hydroxyl group, or to treat or coat a material constituting the porous film to introduce a hydrophilic group, and any organic or inorganic material is suitable as a material of the porous film. It may be a combination of a plurality of porous membranes; in the porous membrane, the pore diameter of the membrane is preferably 0.2 μm or more, and the thickness is preferably 10 μm to 500 μm, more preferably 50 μm to 250 μm, in order to allow the solution to pass therethrough. In addition, in the present invention, the upper end and the lower end of the purification tube are defined as the lower end of the general purification tube structure, and the upper end is far from the purification membrane position, but the creation is not limited thereto. The one that is joined to the pressure device is called the upper end of the purification tube, and the one used to suck the liquid is called the lower end of the purification tube.
本文中術語「可施以正或負氣體壓力之壓力設備」係包含任 何裝置可提供正或負氣體壓力者,最簡易之裝置如唧筒,可藉由抽或壓該唧管體內的推桿而提供正或或負氣體壓力;抑或如習知技術中的流體控制裝置、移液器、泵或氣壓缸,其包含一氣壓閥以及一壓力器,可受控制而產生正或負氣體壓力,其中,使溶液可穿透半透膜之壓力值為10kPa至300kPa,優選為40kPa至200kPa,最優選之壓力值為60kPa。The term "pressure equipment capable of applying positive or negative gas pressure" is used herein. Where the device can provide positive or negative gas pressure, the simplest device such as a cartridge can provide positive or negative gas pressure by pumping or pressing the push rod in the manifold; or a fluid control device as in the prior art a pipette, a pump or a pneumatic cylinder comprising a pneumatic valve and a pressure regulator capable of being controlled to generate a positive or negative gas pressure, wherein the pressure of the solution to penetrate the semipermeable membrane is from 10 kPa to 300 kPa, preferably From 40 kPa to 200 kPa, the most preferred pressure value is 60 kPa.
本文中術語「清洗液」(或稱「緩衝液」)係包含習知技術中任何可用於清洗純化管的液體,其包含但不限於水、酒精或其他不會改變半透膜電性或極性之緩衝液,亦即該清洗液能夠洗出核酸混合物溶液中的雜質,該雜質是與核酸一起吸附於該半透膜上,就此方面而言,該清洗液僅使雜質由半透膜上被沖提,而不會使核酸被沖提,為達到此目的,由於核酸難溶於水性的有機溶液,因此使用適合的水性有機溶液,皆在本創作之範圍當中,例如醇類,包含甲醇、乙醇、異丙醇、正丙醇或丁醇,優選為乙醇。The term "cleaning fluid" (or "buffer") as used herein, includes any liquid of the prior art that can be used to clean a purification tube, including but not limited to water, alcohol or others that do not alter the electrical or polar properties of the semipermeable membrane. a buffer, that is, the cleaning liquid capable of washing out impurities in the nucleic acid mixture solution, the impurities being adsorbed on the semipermeable membrane together with the nucleic acid, and in this respect, the cleaning liquid only causes the impurities to be on the semipermeable membrane Rathering, without nucleating the nucleic acid, in order to achieve this, since the nucleic acid is poorly soluble in the aqueous organic solution, the use of suitable aqueous organic solutions is within the scope of this creation, such as alcohols, including methanol, Ethanol, isopropanol, n-propanol or butanol, preferably ethanol.
本文中術語「充提液」(或稱「洗提緩衝液」)係包含習知技術中任何可用於將核酸由該半透膜上解離的液體,其包含可將半透膜的極性或電性改變,而使核酸由其上解離下來之液體,例如為含有1.2M NaCl、50mM 3-(N-嗎啉)丙磺酸(MOPS)、15%乙醇且pH 8.0之緩衝液;或如為含有0.5M乙酸銨、10mM乙酸鎂(pH7.5)及1.5mM EDTA之緩衝液;或如為含有1.25M NaCl、50mM Tris-HCl pH 8.5及15%異丙醇之緩衝液等。The term "extraction solution" (or "elution buffer") as used herein encompasses any liquid of the prior art that can be used to dissociate nucleic acids from the semipermeable membrane, including polar or electrical properties of the semipermeable membrane. a liquid in which the nucleic acid is dissociated, for example, a buffer containing 1.2 M NaCl, 50 mM 3-(N-morpholine)propanesulfonic acid (MOPS), 15% ethanol, and pH 8.0; A buffer containing 0.5 M ammonium acetate, 10 mM magnesium acetate (pH 7.5) and 1.5 mM EDTA; or a buffer containing 1.25 M NaCl, 50 mM Tris-HCl pH 8.5 and 15% isopropanol, and the like.
在本創作之技術領域中存在有一種技術偏見,亦即本創作所屬技術領域之技藝人士通常認為,須要將具有核酸的檢體,由純化管上端提供,而使其中的核酸與半透膜結合後,殘餘檢體由純化管的另外一端(純 化管下端)排出;然而,本創作克服了技術偏見,在對該純化管提供具有核酸的檢體之前,便先將純化管一端(純化管上端)與壓力設備結合,而使萃取核酸時所須用到的所有液體材料(包含具有核酸的檢體、核酸已被半透膜吸附的殘餘檢體、清洗液、廢棄清洗液、充提液或溶有核酸之充提液)均僅由純化管的另一端(純化管下端)進出。使用本創作之部件及容置套組的優點在於,由於所有液體材料僅由純化管的一端進出,此外,由於當該具有核酸之檢體由純化管下端吸取而通過半透膜後,核酸先與該半透膜結合,而當對該純化管施以正氣壓,將該檢體排出時,檢體又會再通過一次半透膜並於純化管下端排出,若有殘餘未與該半透膜結合的核酸,可有再次的機會與半透膜結合,因此,於本創作中操作一次的結合步驟,實際上已經重複了兩次的結合步驟;而清洗步驟以及收集步驟亦為相同原理,於本創作中操作一次的清洗或收集步驟中,實際上已經重複了兩次的清洗和收集步驟,故而萃取核酸的量會增加,且效率更高。此外,在萃取過程中還可反覆利用壓力裝置提供的正/負氣壓,使萃取所用之液體可反覆通過半透膜,又進一步增進核酸結合、清洗或沖提的效率,有效提升核酸的萃取量;相較於先前技術中,所有反應液體均是一次性地通過半透膜,而液體即被排掉或抽走,但本創作之方法則可增進萃取量且提高萃取效率。There is a technical prejudice in the technical field of the present invention, that is, those skilled in the art of the present invention generally believe that it is necessary to provide a nucleic acid-containing sample from the upper end of the purification tube to bind the nucleic acid to the semipermeable membrane. After that, the residual sample is from the other end of the purification tube (pure The lower end of the tube is discharged; however, this creation overcomes the technical bias, and before the purification tube is provided with the sample having the nucleic acid, the one end of the purification tube (the upper end of the purification tube) is combined with the pressure device, so that the nucleic acid is extracted. All liquid materials to be used (including samples with nucleic acids, residual samples with nucleic acid adsorbed by semipermeable membrane, cleaning solution, waste cleaning solution, eluent or nucleic acid-encapsulated extract) are only purified. The other end of the tube (lower end of the purification tube) is in and out. The advantage of using the created component and the accommodating set is that since all the liquid material is only in and out of one end of the purification tube, in addition, since the sample having the nucleic acid is taken up through the semipermeable membrane by the lower end of the purification tube, the nucleic acid is first Combined with the semipermeable membrane, when the purification tube is subjected to positive air pressure and the sample is discharged, the sample is again passed through a semipermeable membrane and discharged at the lower end of the purification tube, if any residue is not translucent. The membrane-bound nucleic acid may have a chance to combine with the semipermeable membrane. Therefore, the binding step of one operation in the present creation has actually repeated the binding step twice; the washing step and the collecting step are also the same principle. In the cleaning or collection step of one operation in this creation, the cleaning and collection steps have actually been repeated twice, so the amount of extracted nucleic acid is increased and the efficiency is higher. In addition, during the extraction process, the positive/negative gas pressure provided by the pressure device can be repeatedly used, so that the liquid used for the extraction can repeatedly pass through the semi-permeable membrane, thereby further improving the efficiency of nucleic acid binding, washing or elution, and effectively increasing the extraction amount of the nucleic acid. Compared with the prior art, all the reaction liquids pass through the semipermeable membrane at one time, and the liquid is drained or pumped away, but the method of the present invention can increase the extraction amount and improve the extraction efficiency.
再者,使用本創作之部件及容置套組,所有使用的液體材料均可「原位吸取/排除」,亦即,萃取過程中的液體材料由何處被吸取,即可排回其被吸取之處或其他所欲之容器中,而不須使用特出的廢液桶進行收集。因此,若使用一行的純化匣時,而當萃取核酸結束後,所有的廢液均還是回到其原本於純化匣中的位置,而可直接將該使用過後的純化匣丟 棄,不僅方便且亦可減少交叉汙染的風險。Furthermore, with the components and housing kits of the present invention, all liquid materials used can be "absorbed/extracted in situ", that is, where the liquid material in the extraction process is sucked, it can be discharged back to it. Collect in a suction or other desired container without using a special waste container. Therefore, if a row of purified hydrazine is used, and when the nucleic acid is extracted, all the effluent is returned to its original position in the purified sputum, and the purified sputum after use can be directly discarded. Discarding is not only convenient but also reduces the risk of cross-contamination.
首先,參見第3圖,其創作之氣壓式萃取核酸裝置之一實施例示意圖。該氣壓式萃取核酸裝置包含一純化管20以及一可施以正或負氣體壓力之壓力設備60。該純化管20為管柱部件之一實施態樣。該純化管20上端與該壓力設備60氣密接合,而該純化管由上而下貫通,分別為一上頸部201(即第二上部)、一中間管體部202(即第二長柱部)、一純化膜203(即半透膜)以及一下尖部204(即第二下部),該純化膜203位於該中間管體部202之內,該下尖部204具有一通孔。藉由該裝置,首先進行「結合步驟」:開啟該壓力設備60對該純化管20施以負氣壓,該純化管20之下尖部204吸取含有核酸之檢體,使檢體通過該純化膜203,而使該核酸與該純化膜203電性或極性結合;開啟該壓力設備60對該純化管20施以正氣壓,使殘餘檢體以相反方向再度通過該純化膜203後,由純化管20之下尖部204流出,此步驟可視需要重複一至多次。其中,該檢體中的核酸為結合於純化膜上的預期材料的其中之一示例,該預期材料亦可視需要而有所不同,蛋白質、多肽、醣類、酯質亦可作為預期材料。First, referring to Fig. 3, a schematic diagram of one embodiment of a pneumatic pressure extraction nucleic acid device is created. The pneumatic extraction nucleic acid device comprises a purification tube 20 and a pressure device 60 that can apply a positive or negative gas pressure. The purification tube 20 is an embodiment of a column member. The upper end of the purification tube 20 is hermetically joined to the pressure device 60, and the purification tube is penetrated from top to bottom, and is an upper neck portion 201 (ie, a second upper portion) and an intermediate tube portion 202 (ie, a second long column). a purification membrane 203 (ie, a semipermeable membrane) and a lower tip 204 (ie, a second lower portion), the purification membrane 203 being located within the intermediate tubular portion 202, the lower tip portion 204 having a through hole. With the apparatus, a "binding step" is first performed: the pressure device 60 is turned on to apply a negative air pressure to the purification tube 20, and the lower portion 204 of the purification tube 20 sucks a sample containing nucleic acid to pass the sample through the purification membrane. 203, the nucleic acid is electrically or polarly bonded to the purification membrane 203; the pressure device 60 is turned on to apply positive pressure to the purification tube 20, and the residual sample is passed through the purification membrane 203 in the opposite direction, and then the purification tube is passed through the purification tube. The tip 204 exits below 20, and this step can be repeated one to many times as needed. Wherein, the nucleic acid in the sample is one of the expected materials bound to the purified membrane, and the expected material may also be different as needed, and proteins, polypeptides, sugars, and esters may also be used as the expected materials.
接著進行「收集步驟」:開啟該壓力設備60對該純化管20施以負氣壓,利用該純化管20之下尖部204吸取沖提液,使該沖提液通過純化膜203後,改變該純化膜203電性或極性使核酸與純化膜203分離並溶於沖提液中;開啟該壓力設備60對該純化管20施以正氣壓,使該溶有核酸之沖提液以相反方向再度通過該純化膜203後,由該純化管20之下尖部204排出並收集,此收集步驟可視需要重複一至多次。而使用者可依據需要,在結合步驟完成後進一步進行一至多次之清洗步驟。Then, the "collection step" is performed: the pressure device 60 is turned on to apply a negative air pressure to the purification tube 20, and the extract liquid is sucked by the lower tip portion 204 of the purification tube 20, and the extract liquid is passed through the purification membrane 203 to change the The purified membrane 203 is electrically or polarized to separate the nucleic acid from the purification membrane 203 and dissolved in the extract; the pressure device 60 is turned on to apply positive pressure to the purification tube 20, and the nucleic acid-dissolved solution is re-inverted in the opposite direction. After passing through the purification membrane 203, it is discharged and collected from the lower tip 204 of the purification tube 20, and the collection step can be repeated one to many times as needed. The user can further perform one or more cleaning steps after the bonding step is completed as needed.
根據本創作之氣壓式萃取核酸裝置,該純化管20可利用各種習知技術中已存在的純化管,市面上不同廠牌的純化管均可利用於本創作。再者,為了避免純化管20內的檢體受到負氣壓的吸取,沖到壓力設備60上造成汙染,圖中可見,該純化管20上端與該壓力設備60中間可進一步設有一具濾膜901之轉接頭90,該轉接頭90係與純化管20上端(即上頸部201)以及壓力設備60氣密接合。According to the pneumatic pressure extraction nucleic acid device of the present invention, the purification tube 20 can utilize various purification tubes existing in various prior art, and the purification tubes of different brands on the market can be utilized in the present creation. Furthermore, in order to prevent the sample in the purification tube 20 from being absorbed by the negative air pressure, it is flushed onto the pressure device 60 to cause pollution. As shown in the figure, a filter membrane 901 may be further disposed between the upper end of the purification tube 20 and the pressure device 60. The adapter 90 is in airtight engagement with the upper end of the purification tube 20 (i.e., the upper neck 201) and the pressure device 60.
此外,為了使吸取液體或收集液體時更方便操作,在純化管20之下尖部204可進一步設有與其氣密接合之移液吸管80,藉此,純化管20可利用該移液吸管80吸取少量液體或將純化的檢體收集到微離心管中。該移液吸管80為吸取部件之一實施態樣。In addition, in order to facilitate the handling of the liquid or the collection of the liquid, the tip portion 204 of the purification tube 20 may be further provided with a pipetting pipe 80 that is hermetically joined thereto, whereby the pipette 80 can be utilized by the purification pipe 20. Aspirate a small amount of liquid or collect the purified sample into a microcentrifuge tube. The pipetting pipette 80 is an embodiment of the suction member.
在本創作較佳之實施例中,該移液吸管上端結構為一套體,該套體可氣密地包覆該純化管部分的中間管體至下端處,使其套合於該純化管,且該移液吸管與該純化管接合處的結構係與不同廠牌的純化管具有通用性,而可廣泛應用於各類型的純化管,該手段例如但不限於該移液吸管之套體與該純化管接合處的結構係使用橡膠材質,使其為彈性結構,而可與不同規格之純化管接合;或該套體部分具有兩層不同的斜度,第一層靠近純化管中間管體的斜度較平緩,第二層靠近純化管下端的斜度較陡,利用此兩層不同之斜度而使其可適用並氣密地套合於市面上各種廠牌的純化管。In a preferred embodiment of the present invention, the upper end structure of the pipette is a set body, and the sleeve body can hermetically cover the intermediate pipe body of the purification pipe portion to the lower end to fit the purification pipe. Moreover, the structure of the pipette and the purification pipe joint is versatile with the purification tube of different brands, and can be widely applied to various types of purification tubes, such as but not limited to the sleeve of the pipette and The structure of the joint of the purification tube is made of rubber material to make it elastic structure, and can be joined with different purification tubes; or the sleeve portion has two different slopes, and the first layer is close to the middle tube of the purification tube The slope of the second layer is relatively steep near the lower end of the purification tube, and the two layers have different slopes to make it suitable for gas-tight fitting in various purification tubes of various brands on the market.
此外,為使該轉接頭90與該移液吸管80與該純化管接合處的結構係與不同廠牌的純化管具有通用性,可將該轉接頭90與該移液吸管80與該純化管20接合處的結構係使用橡膠材質,使其為彈性結構,而可與不 同規格之純化管20接合。在本創作中,由於元件間皆必須氣密接合,才可利用氣壓式方式萃取核酸。各個元件間氣密接合的方式可使用任何習知的技術,如增設O型環等方式,並未有所限制。In addition, in order to make the adapter 90 and the structure of the pipette 80 and the purification pipe joint with the purification pipe of different brands, the adapter 90 and the pipette 80 can be used. The structure of the joint of the purification tube 20 is made of a rubber material to make it an elastic structure, and the The purification tube 20 of the same specification is joined. In this creation, the nucleic acid can be extracted by a pneumatic method because the components must be hermetically joined. The manner in which the components are hermetically joined may be any conventional technique, such as the addition of an O-ring, and is not limited.
第4圖為本創作之氣壓式萃取核酸裝置之另一實施例示意圖。第4圖所顯示之萃取裝置的結構基本上與第3圖所顯示之萃取裝置的結構相同,但仍有若干不同處,以適應不同操作需求。其差異處於以下詳述之。純化管20更具有自上頸部201向外延伸的蓋部205及設置於純化膜203上方的O環206,蓋部205係用以密封上頸部201上方之開口,以避免進行其他處理時純化管20遭受汙染。而O環206係用以固定純化膜203,以避免於萃取處理或其他處理時純化膜203之位置變動。Fig. 4 is a schematic view showing another embodiment of the pneumatic pressure extraction nucleic acid device of the present invention. The structure of the extraction apparatus shown in Fig. 4 is basically the same as that of the extraction apparatus shown in Fig. 3, but there are still several differences to accommodate different operational requirements. The differences are detailed below. The purification tube 20 further has a lid portion 205 extending outward from the upper neck portion 201 and an O-ring 206 disposed above the purification membrane 203. The lid portion 205 is used to seal the opening above the upper neck portion 201 to avoid other processing. The purification tube 20 is contaminated. The O-ring 206 is used to fix the purification membrane 203 to avoid the positional change of the purification membrane 203 during the extraction treatment or other treatment.
該轉接頭90為應接部件之一實施態樣。該轉接頭90更具有第三上部902、第三長柱部904、及第三下部906。具體而言,濾膜901係位於第三長柱部904之內,而第三長柱部904係夾於第三上部902及第三下部906之間且與第三上部902及第三下部906連通,因此第三下部906及第三長柱部904配合抵接純化管20之上頸部201或中間管體部202之內周,且藉由濾膜901防止樣品內的溶液、預洗緩衝液、後洗緩衝液、或洗提緩衝液等特定液體於萃取過程中由第三下部906朝第三上部902過度流溢。The adapter 90 is an embodiment of the component to be connected. The adapter 90 further has a third upper portion 902, a third elongated post portion 904, and a third lower portion 906. Specifically, the filter membrane 901 is located within the third long column portion 904, and the third long column portion 904 is sandwiched between the third upper portion 902 and the third lower portion 906 and with the third upper portion 902 and the third lower portion 906. The third lower portion 906 and the third long post portion 904 are engaged to abut the inner circumference of the neck portion 201 or the intermediate tube portion 202 of the purification tube 20, and the solution in the sample is prevented from being pre-washed by the filter 901. A specific liquid such as a liquid, a post-wash buffer, or an elution buffer overflows excessively from the third lower portion 906 toward the third upper portion 902 during the extraction process.
在較佳實施例中,轉接頭90之第三長柱部904具有刻紋908,用以夾持濾膜901,且第三上部902之內徑大於第三長柱部904之內徑,而第三長柱部904之內徑大於第三下部906之內徑,藉此使得第三下部906及第三長柱部904可更佳地配合抵接純化管20之上頸部201或中間管體部202之內周。在更佳實施例中,濾膜901上方基本上無須再設置用以固定濾膜901的O 環。In the preferred embodiment, the third long post portion 904 of the adapter 90 has a score 908 for holding the filter 901, and the inner diameter of the third upper portion 902 is greater than the inner diameter of the third long post portion 904. The inner diameter of the third long post portion 904 is larger than the inner diameter of the third lower portion 906, so that the third lower portion 906 and the third long post portion 904 can better fit against the neck 201 or the middle of the purification tube 20 The inner circumference of the tubular body portion 202. In a more preferred embodiment, there is substantially no need to provide an upper portion of the filter 901 for fixing the filter 901. ring.
由圖中可見,在本創作較佳之實施例中,移液吸管80由上而下包含第一上部802、中間部804、及吸取部806,其中中間部804係連通於第一上部802下方且內徑小於第一上部802之內徑;而該吸取部806係連通於中間部804下方且內徑小於中間部804之內徑,且遠離中間部804之一端的內徑比靠近中間部804之一端的內徑還小,亦即吸取部806在遠離中間部804的方向上逐漸變細,以便吸取液體。具體而言,該第一上部802可為一套體,該套體可氣密地由該純化管部分的中間管體部202至下尖部204處套合。據此,使該移液吸管80可廣泛應用於各種不同類型的純化管,且當與純化管20結合時即使有所偏移,亦可相結合而不會滑移分離。亦即,第一上部802及中間部804配合抵接純化管20之外周,且可經由吸取部806將預洗緩衝液、後洗緩衝液、或洗提緩衝液等特定液體吸至純化管20,以便進行萃取相關處理。As can be seen from the drawings, in the preferred embodiment of the present invention, the pipetting pipe 80 includes a first upper portion 802, an intermediate portion 804, and a suction portion 806 from top to bottom, wherein the intermediate portion 804 is communicated with the first upper portion 802 and The inner diameter is smaller than the inner diameter of the first upper portion 802; and the suction portion 806 is communicated with the inner portion 804 below and the inner diameter is smaller than the inner diameter of the intermediate portion 804, and the inner diameter away from the one end of the intermediate portion 804 is closer to the intermediate portion 804. The inner diameter of one end is also small, that is, the suction portion 806 is tapered in a direction away from the intermediate portion 804 to draw liquid. In particular, the first upper portion 802 can be a set of bodies that can be airtightly engaged from the intermediate tubular body portion 202 to the lower pointed portion 204 of the purified tubular portion. Accordingly, the pipetting pipette 80 can be widely applied to various types of purification tubes, and even if it is combined with the purification tube 20, it can be combined without slipping separation. That is, the first upper portion 802 and the intermediate portion 804 cooperate to abut against the outer circumference of the purification tube 20, and the specific liquid such as the pre-wash buffer, the post-wash buffer, or the elution buffer can be sucked to the purification tube 20 via the suction portion 806. In order to carry out extraction related processing.
再者,移液吸管80之第一上部802環設有呈現放射狀的複數個肋材808,使得當移液吸管80藉由複數個肋材808而支持於後述的容置套組或類似容器上時,氣體可經由該複數個肋材彼此之間的間隙流動,進而避免該容置套組或類似容器於吸取特定液體時受到移液吸管80氣密蓋合,造成該容置套組或類似容器內壓小於環境壓力而無法順利移動移液吸管80的情況。Furthermore, the first upper portion 802 of the pipetting pipe 80 is provided with a plurality of ribs 808 that are radially formed, so that when the pipetting pipe 80 is supported by a plurality of ribs 808 in a housing set or the like described later. In the upper case, the gas can flow through the gap between the plurality of ribs, thereby preventing the receiving sleeve or the like from being hermetically covered by the pipetting pipe 80 when sucking the specific liquid, thereby causing the receiving set or The case where the internal pressure of the container is less than the ambient pressure and the pipette 80 cannot be smoothly moved.
接著,請參見第5圖,其為本創作之氣壓式萃取核酸裝置之另一實施例示意圖。可見該氣壓式萃取核酸裝置可為一流體控制裝置70,該流體控制裝置70即係一種可施以正或負氣體壓力之壓力元件,亦可為針 筒。該流體控制裝置70包含一管體701、設置於該管體701內之一推桿702及可拆卸式地與管體701接合之一針頭組件703,其特徵在於該管體內701之推桿702下方設有一可與核酸電性結合之純化膜203。藉由本創作的裝置,可依循上述的方法,直接使用該流體控制裝置70利用推桿702的抽吸及推排,進行「結合步驟」、「清洗步驟」以及「收集步驟」;詳言之,先利用推桿702上拉時所產生的負氣壓,使針頭組件703或者移液吸管80吸取檢體,當檢體通過針頭進入管體701內時,檢體由下往上通過該純化膜203,檢體內帶有負電的核酸會與純化膜203電性或極性結合,而殘餘的檢體藉由推動推桿702產生的正氣壓,由上往下再度通過該純化膜203後由針頭排出,完成「結合步驟」;接著,再次將推桿702上拉,並由針頭組件703吸取清洗液,該清洗液由下往上通過該純化膜203,使純化膜203上的雜質被受清洗後而可提高核酸的純度,並再度推動推桿702產生的正氣壓,將清洗液由上往下通過該純化膜203後由針頭排出,完成「清洗步驟」,該清洗步驟可依照需求重複一到多次;最後,再次將推桿702上拉,並由針頭吸取沖提液,該沖提液由下往上通過該純化膜203,使特殊鹽度及pH值的沖提液改變純化膜203的電性或極性,讓核酸由半透膜上沖提出來而溶於沖提液中,並將推桿702推動使溶有核酸的沖提液由上往下通過該純化膜203後經由針頭排出而收集於收集管中,完成「收集步驟」。Next, please refer to FIG. 5, which is a schematic diagram of another embodiment of the pneumatic pressure extraction nucleic acid device of the present invention. It can be seen that the pneumatic extraction nucleic acid device can be a fluid control device 70, which is a pressure element that can apply positive or negative gas pressure, or can be a needle. cylinder. The fluid control device 70 includes a tube body 701, a push rod 702 disposed in the tube body 701, and a needle assembly 703 detachably coupled to the tube body 701. The push rod 702 of the tube body 701 is characterized. A purification membrane 203 electrically coupled to the nucleic acid is provided below. According to the device of the present invention, the fluid control device 70 can directly use the suction and the pushing of the push rod 702 to perform the "combination step", the "cleaning step" and the "collection step"; in detail, First, the needle assembly 703 or the pipetting pipe 80 is used to suck the sample by the negative air pressure generated when the push rod 702 is pulled up. When the sample enters the tube body 701 through the needle, the sample passes through the purified film 203 from bottom to top. The negatively charged nucleic acid in the sample is electrically or polarly bound to the purification membrane 203, and the residual sample is discharged from the needle through the purification membrane 203 by pushing the positive air pressure generated by the push rod 702 from top to bottom. The "binding step" is completed; then, the pusher 702 is pulled up again, and the cleaning liquid is sucked by the needle assembly 703, and the cleaning liquid passes through the purification film 203 from bottom to top, so that the impurities on the purification film 203 are cleaned. The purity of the nucleic acid can be increased, and the positive air pressure generated by the push rod 702 can be pushed again. The cleaning liquid is discharged from the top to the bottom through the purified film 203, and then the needle is discharged to complete the "cleaning step", which can be repeated one or more times according to requirements. Times Finally, the pusher 702 is pulled up again, and the extract is sucked by the needle, and the extract passes through the purified membrane 203 from bottom to top, so that the extract of the special salinity and pH changes the electricity of the purified membrane 203. Sexual or polar, the nucleic acid is flushed from the semipermeable membrane and dissolved in the extract, and the push rod 702 is pushed to pass the nucleic acid-dissolved extract from the top to the bottom through the purified membrane 203 and then discharged through the needle. Collected in the collection tube to complete the "collection step."
第6圖顯示流體控制裝置70之另一實施例。與第5圖之實施例不同者在於並未具有純化膜203、而針頭組件703實質上為轉接頭90所取代。具體言之,該流體控制裝置70包含一管體701、設置於該管體701內之一推桿702及可拆卸地或一體成型地與管體701下方連通接合之轉接頭90。 該轉接頭90更具有第三上部902、第三長柱部904、及第三下部906。其中,第三長柱部904係夾於第三上部902及第三下部906之間且與第三上部902及第三下部906連通,因此第三下部906及第三長柱部904配合抵接純化管20之上頸部201或中間管體部202之內周。在較佳實施例中,第三上部902之內徑大於第三長柱部904之內徑,而第三長柱部904之內徑大於第三下部906之內徑,藉此使得第三下部906及第三長柱部904可更佳地配合抵接純化管20之上頸部201或中間管體部202之內周。藉由本創作的裝置,再配合使用純化管20及移液吸管80,可如前述實施例般輕易達成萃取預期材料的功效。再者,如此配置可使得流量控制裝置70於使用完畢後即加以拋棄,而不用再度清洗使用,增加樣品汙染之可能性。FIG. 6 shows another embodiment of the fluid control device 70. The difference from the embodiment of Fig. 5 is that the purification membrane 203 is not provided, and the needle assembly 703 is substantially replaced by the adapter 90. Specifically, the fluid control device 70 includes a tubular body 701, a push rod 702 disposed in the tubular body 701, and a adaptor 90 detachably or integrally formed in communication with the lower portion of the tubular body 701. The adapter 90 further has a third upper portion 902, a third elongated post portion 904, and a third lower portion 906. The third long post portion 904 is sandwiched between the third upper portion 902 and the third lower portion 906 and communicates with the third upper portion 902 and the third lower portion 906. Therefore, the third lower portion 906 and the third long post portion 904 are mated. The inner circumference of the neck 201 or the intermediate tube portion 202 above the purification tube 20 is purified. In a preferred embodiment, the inner diameter of the third upper portion 902 is greater than the inner diameter of the third long post portion 904, and the inner diameter of the third long post portion 904 is greater than the inner diameter of the third lower portion 906, thereby making the third lower portion The 906 and the third long post portion 904 can better fit against the inner circumference of the neck portion 201 or the intermediate tube portion 202 above the purification tube 20. With the device of the present invention, in combination with the purification tube 20 and the pipette pipette 80, the effect of extracting the desired material can be easily achieved as in the foregoing embodiment. Moreover, such a configuration allows the flow control device 70 to be discarded after use, without the need for re-cleaning, increasing the likelihood of sample contamination.
本創作之另一方面係利用本創作之方法所設計的氣壓式萃取核酸之自動化機台(未圖示),其包含一機械手臂、一組或一組以上之唧筒以及一操作檯,且該操作檯包含一容置套組150。在本創作之一較佳實施例中,該自動化機台可進一步包含一加熱模組及/或一振盪器,使檢體在操作過程中可選擇性地受振盪或加熱,以提高核酸純化之產量。Another aspect of the present invention is an automated machine for pneumatic extraction of nucleic acids (not shown) designed by the method of the present invention, comprising a robot arm, one or more sets of cartridges, and a console, and The console includes a housing set 150. In a preferred embodiment of the present invention, the automated machine may further comprise a heating module and/or an oscillator to selectively oscillate or heat the sample during operation to improve nucleic acid purification. Yield.
第7圖為於本創作一實施例中的用以純化出預期材料的容置套組150示意圖,該容置套組150包含:一具有一上頸部、一中間管體部、一半透膜以及一下尖部之純化管20、一具濾膜之轉接頭90、一移液吸管80、一用於容置檢體之孔盤(簡稱檢體套管100)、至少一個用於容置緩衝液之孔盤(簡稱緩衝液套管120);及一用於容置萃取後產物之孔盤(簡稱產物套管110)。Figure 7 is a schematic view of a housing kit 150 for purifying a desired material in an embodiment of the present invention. The housing kit 150 includes: an upper neck portion, an intermediate tube portion, and a half-permeable membrane. And a purification tube 20 at the tip, a filter adapter 90, a pipette 80, a hole plate for accommodating the sample (referred to as the sample sleeve 100 for short), at least one for accommodating a buffer tray (abbreviated as buffer sleeve 120); and a well plate (referred to as product sleeve 110) for accommodating the extracted product.
此外,於本創作一實施例中,該容置套組包含:(a)一具有 半透膜之純化管、(b)一具濾膜之轉接頭、(c)一移液吸管、(d)一用於容置檢體之孔盤、(e)至少一個用於容置緩衝液之孔盤;及(f)一用於容置萃取後產物之孔盤。其中,上述套組中之(a)至(c)組件可為一體成形者,於本創作之一較佳實施例中,該容置套組係一體排列為一行純化匣之形式。In addition, in an embodiment of the present creation, the accommodating set includes: (a) one having a semi-permeable membrane purification tube, (b) a filter membrane adapter, (c) a pipette pipette, (d) a well plate for accommodating the sample, and (e) at least one for accommodating a well plate for a buffer; and (f) a well plate for accommodating the product after extraction. The components (a) to (c) in the above kit may be integrally formed. In a preferred embodiment of the present invention, the accommodating kits are integrally arranged in the form of a row of purified crucibles.
根據本創作的氣壓式萃取核酸之自動化機台,其機械手臂上具有唧筒,唧筒前方具有尖端係用於組合該容置套組150內的轉接頭90、純化管20以及移液吸管80(由上往下的順序),當此三者組合完畢(以下簡稱組合件),唧筒可與組合件氣密接合後,提供負氣壓使移液吸管80吸取容置套組150內檢體套管100中的檢體至純化管中,使檢體中的核酸與其內的半透膜電性或極性反應,且轉接頭90可避免檢體上沖至唧筒,而避免汙染,當反應完成後,唧筒給予正氣壓,純化管20將殘餘檢體經由移液吸管80直接排入容置套組150內檢體套管100(此為「結合步驟」),其中,於該結合步驟中,可重複將該檢體通過該純化管20一至多次,提高核酸結合於半透膜之量;接著,機器手臂機械式地帶動組合件至容置套組150中裝填有清洗液的孔盤上端(即緩衝液套管120),提供負氣壓使移液吸管80吸取清洗液至純化管20中,經清洗後,唧筒提供正氣壓,將清洗液排入原先吸取出來的同一孔盤中(此為「清洗步驟」),該清洗步驟可重複一至多次;而當清洗步驟結束後,可進一步將該純化管20以加熱機構加熱以蒸散清洗液中的乙醇,及/或透過多次的以唧筒提供正/負氣壓使該半透膜乾燥;最後,機器手臂機械式地帶動組合件至容置套組150中裝填有沖提液的孔盤上端(即緩衝液套管120),唧筒提供負氣壓使移液吸管吸取沖提液至純化管20中,使電性/極性結合於半透膜上的核酸溶出至沖提液中,接著唧筒提供正氣壓,將沖提液 排入原先吸取出來的同一孔盤中,或是機器手臂可機械式地帶動組合件至容置套組150之產物套管110中,收集所純化的核酸(此為「收集步驟」),該收集步驟可重複一至多次,亦即,將同一沖提液重覆通過該半透膜上一至多次,使核酸的萃取量可有效提高。The automatic machine for extracting nucleic acid according to the present invention has a cylinder on the robot arm, and a tip end in front of the cylinder for combining the adapter 90, the purification tube 20 and the pipette 80 in the accommodation set 150 ( From the top to the bottom), when the three are combined (hereinafter referred to as the assembly), the cartridge can be airtightly engaged with the assembly, and a negative air pressure is provided to cause the pipette pipette 80 to suck the sample casing in the receiving sleeve 150. The sample in 100 is in the purification tube, so that the nucleic acid in the sample reacts with the semi-permeable membrane in the sample or the polarity, and the adapter 90 can prevent the sample from rushing to the cartridge and avoid contamination, when the reaction is completed. The cartridge is given a positive air pressure, and the purification tube 20 directly discharges the residual sample into the sample sleeve 100 in the housing kit 150 via the pipette 80 (this is a "binding step"), wherein, in the bonding step, The sample is repeatedly passed through the purification tube 20 one or more times to increase the amount of nucleic acid bound to the semipermeable membrane; then, the robot arm mechanically drives the assembly to the upper end of the orifice plate filled with the cleaning liquid in the housing set 150 ( That is, the buffer sleeve 120) provides a negative air pressure to make the pipette 8 0 sucking the cleaning liquid into the purification tube 20, after cleaning, the cylinder provides a positive air pressure, and the cleaning liquid is discharged into the same orifice plate that was originally sucked out (this is a "cleaning step"), and the cleaning step can be repeated one to several times; When the washing step is finished, the purification tube 20 may be further heated by a heating mechanism to evaporate the ethanol in the cleaning liquid, and/or the semi-permeable membrane may be dried by supplying a positive/negative pressure to the cylinder by a plurality of times; finally, the machine The arm mechanically drives the assembly to the upper end of the orifice plate (ie, the buffer sleeve 120) filled with the liquid in the accommodating sleeve 150, and the cartridge provides a negative air pressure to allow the pipette to draw the extract into the purification tube 20. The nucleic acid that binds the electrical/polarity to the semipermeable membrane is eluted into the extract, and then the cartridge provides positive air pressure, and the extract is extracted. Discharge into the same orifice plate that was originally sucked out, or the robot arm can mechanically drive the assembly into the product sleeve 110 of the accommodating sleeve 150 to collect the purified nucleic acid (this is a "collection step"), which The collecting step can be repeated one or more times, that is, the same extract is repeatedly passed through the semipermeable membrane one or more times, so that the extraction amount of the nucleic acid can be effectively improved.
該容置套組150可為兩個分開的組件,亦可形成一體成型的組件,並未限制。此外,容置套組150中的緩衝液套管120可根據需求而有不同的數量,但其排列方式最佳為根據萃取核酸時的步驟,依序為細胞溶解液、清洗液、酒精、水或沖提液,藉此,當點膠機帶動組合件移動時,可有順序地一步步直線移往後方進行核酸萃取。The accommodating sleeve 150 can be two separate components, and can also form an integrally formed component, which is not limited. In addition, the buffer sleeves 120 in the housing set 150 can be different in number according to requirements, but the arrangement is optimal according to the steps in the process of extracting nucleic acids, which are sequentially cell lysate, washing solution, alcohol, water. Or the extract liquid, whereby when the dispenser drives the assembly to move, the nucleic acid extraction can be carried out in a stepwise step by step.
此外,由於該含有核酸的檢體通常係包含溶解緩衝液(lysis buffer)以打破檢體中所含細胞的細胞膜而使其釋放出核酸,該緩衝液中含有大量的界面活性劑,故而當「結合步驟」進行完畢後,將殘餘檢體排出時,若排出至空的孔盤中,容易產生大量氣泡而不利於操作,因此,於一較佳之實施例中,該容置套組150可包含一用於容置該殘餘檢體之孔盤(圖中未示),且其中該孔盤中包含水溶液,則該水溶液可吸收氣泡,使該殘餘檢體排出至該孔盤時不會產生氣泡;其中,水溶液的量並無限制,但較佳為100至500μl,更佳為200至400μl,最佳為300μl。In addition, since the nucleic acid-containing sample usually contains a lysis buffer to break the cell membrane of the cells contained in the sample to release the nucleic acid, the buffer contains a large amount of surfactant, so when After the completion of the step of the step, when the residual sample is discharged, if it is discharged into the empty orifice plate, a large amount of air bubbles are easily generated and the operation is unfavorable. Therefore, in a preferred embodiment, the accommodation set 150 may include An orifice plate (not shown) for accommodating the residual sample, wherein the orifice plate contains an aqueous solution, the aqueous solution can absorb air bubbles, and the residual sample is discharged to the orifice plate without generating bubbles. Here, the amount of the aqueous solution is not limited, but is preferably from 100 to 500 μl, more preferably from 200 to 400 μl, most preferably 300 μl.
再者,當「結合步驟」進行完畢後,由於該半透膜上可能有殘存的檢體,因此,若直接吸取清洗液,容易產生較多氣泡,故而可先吸取一次水溶液,將半透膜上的殘餘檢體清除乾淨,也增加該半透膜的通透性,而能使下一清洗步驟的清洗液較好通過該半透膜,增進該清洗效率,因此,該容置套組150可包含:含有水溶液之孔盤(圖中未示)於該緩衝液套 管120之前,其中,水溶液的量並無限制,但較佳為100至500μl,更佳為200至400μl,最佳為300μl。Furthermore, after the "binding step" is completed, there may be a residual sample on the semipermeable membrane. Therefore, if the cleaning solution is directly sucked, more bubbles are likely to be generated, so that the aqueous solution can be first absorbed and the semipermeable membrane can be absorbed. The remaining sample is cleaned, and the permeability of the semipermeable membrane is also increased, so that the cleaning liquid of the next cleaning step can better pass through the semipermeable membrane, thereby improving the cleaning efficiency. Therefore, the accommodating sleeve 150 is improved. The method may include: an orifice plate (not shown) containing an aqueous solution in the buffer sleeve Before the tube 120, the amount of the aqueous solution is not limited, but is preferably from 100 to 500 μl, more preferably from 200 to 400 μl, most preferably 300 μl.
第8圖顯示容置套組150之另一實施例,其係配合前述之樣品萃取裝置而使用。容置套組150可包含依序並置排列的如下元件:應接部件容置部152、鄰接應接部件容置部152的管柱部件容置部154、鄰接管柱部件容置部154的吸取部件容置部156、鄰接吸取部件容置部156的一或更多加熱套管158、及鄰接一或更多加熱套管158或吸取部件容置部156且容置特定緩衝液的一或更多緩衝液套管120。藉此使得依序容置於對應容置部的應接部件、管柱部件、及吸取部件依序組裝並依序於一或更多緩衝液套管120或一或更多加熱套管158中進行對應萃取相關動作。此外,緩衝液套管120之開口端上有鋁箔封口,而於處理時以針頭或類似裝置加以刺破,藉此避免緩衝液套管120所容置的特定緩衝液遭受汙染。Figure 8 shows another embodiment of a containment kit 150 that is used in conjunction with the aforementioned sample extraction device. The accommodating sleeve 150 may include the following elements arranged in a juxtaposed arrangement: the component receiving portion 152, the column member accommodating portion 154 adjoining the component accommodating portion 152, and the suction of the adjacent column member accommodating portion 154 a component accommodating portion 156, one or more heating sleeves 158 adjoining the suction member accommodating portion 156, and one or more adjacent to the one or more heating sleeves 158 or the suction member accommodating portion 156 and containing a specific buffer Multiple buffer sleeves 120. Thereby, the component, the column component, and the suction component sequentially placed in the corresponding accommodating portion are sequentially assembled and sequentially in one or more buffer sleeves 120 or one or more heating sleeves 158. Perform corresponding extraction related actions. In addition, the open end of the buffer sleeve 120 has an aluminum foil seal which is pierced by a needle or the like during processing, thereby preventing contamination of the specific buffer contained in the buffer sleeve 120.
在一實施例中,一或更多加熱套管158或一或更多緩衝液套管120之高度略大於前述吸取部件之中間部加吸取部之高度,使得該吸取部件置於加熱套管158或緩衝液套管120上時,不會觸碰到加熱套管158或緩衝液套管120之底部,藉此避免無法吸取一或更多加熱套管158或一或更多緩衝液套管120中的液體。此外,在一實施例中,加熱套管158可與緩衝液套管120之結構相同,亦可用以容置緩衝液。In one embodiment, the height of the one or more heating sleeves 158 or one or more buffer sleeves 120 is slightly greater than the height of the intermediate portion of the suction member plus the suction portion such that the suction member is placed in the heating sleeve 158. Or the buffer sleeve 120 does not touch the bottom of the heating sleeve 158 or the buffer sleeve 120, thereby avoiding the inability to draw one or more heating sleeves 158 or one or more buffer sleeves 120. The liquid in it. In addition, in an embodiment, the heating sleeve 158 can be the same structure as the buffer sleeve 120, and can also be used to accommodate the buffer.
在一實施例中,一或更多緩衝液套管120可分別容置酵素、胞溶緩衝液、鍵結緩衝液、預洗緩衝液、沖洗緩衝液、後洗緩衝液、或洗提緩衝液,以便依序進行對應萃取相關動作。此外,若干緩衝液套管120可僅包含氣體,而無其他緩衝液,以便進行乾燥處理,使純化管20中的純化 膜203上的酒精或其他有機溶劑更容易揮發,以避免干擾到後續處理。在較佳實施例中,容置套組150可包含10個緩衝液套管,分別依序容置酵素、胞溶緩衝液、鍵結緩衝液、預洗緩衝液、三管沖洗緩衝液、後洗緩衝液、氣體、或洗提緩衝液,以便依序進行萃取處理。In one embodiment, one or more buffer sleeves 120 can house an enzyme, a cytolytic buffer, a binding buffer, a prewash buffer, a wash buffer, a post wash buffer, or an elution buffer, respectively. In order to perform corresponding extraction-related actions in sequence. In addition, several buffer sleeves 120 may contain only gas without additional buffer for drying treatment to allow purification in purification tube 20. Alcohol or other organic solvents on film 203 are more readily volatilized to avoid interference with subsequent processing. In a preferred embodiment, the receiving kit 150 can include 10 buffer sleeves for sequentially accommodating the enzyme, the cytolysis buffer, the binding buffer, the prewash buffer, the three tube rinse buffer, and the like. Wash buffer, gas, or elution buffer for sequential extraction.
在一實施例中,一或更多加熱套管158係分隔設置,以便以約65℃之溫度分別加熱,提高加熱效率,加快酒精或洗提緩衝液等有機溶劑的揮發速率,以避免干擾到後續處理。在較佳實施例中,容置套組150可包含兩個加熱套管158,分別用以去除酒精或洗提溶液。其中,去除洗提溶液可增加最終產物的產量。In one embodiment, one or more heating sleeves 158 are spaced apart to heat separately at a temperature of about 65 ° C to increase heating efficiency and speed up the evaporation rate of organic solvents such as alcohol or elution buffer to avoid interference. Follow-up processing. In a preferred embodiment, the receiving kit 150 can include two heating sleeves 158 for removing alcohol or eluting solution, respectively. Among them, the removal of the elution solution can increase the yield of the final product.
在一實施例中,應接部件容置部152、管柱部件容置部154、或吸取部件容置部156分別具有不同大小的圓形開口,以便容置對應的應接部件、管柱部件、或吸取部件。在另一實施例中,管柱部件容置部154更包含長形開口,以便容置管柱部件之蓋部205。In an embodiment, the component receiving portion 152, the column member accommodating portion 154, or the absorbing member accommodating portion 156 respectively have circular openings of different sizes to accommodate corresponding connecting members and column members. Or pick up parts. In another embodiment, the column member receptacle 154 further includes an elongated opening for receiving the cover portion 205 of the tubular member.
以下實施例不應視為過度地限制本創作。本創作所屬技術領域中具有通常知識者可在不背離本創作之精神或範疇的情況下對本文所討論之實施例進行修改及變化,而仍屬於本創作之範圍。The following examples should not be construed as unduly limiting the creation. Modifications and variations of the embodiments discussed herein may be made without departing from the spirit and scope of the invention, and still fall within the scope of the present invention.
[實施例]純化魚肝臟的gDNA[Examples] Purification of gDNA of fish liver
前置作業Front work
所有的試劑均使用QIAamp DNA試劑套組(凱杰生物科技有限公司(Qiagen Taiwan Co.Ltd.))中所附者,內含組織溶解液、細胞溶解液、清洗液I、清洗液II、沖提液及蛋白質分解酶K(proteinase K),以及純化管,其中該純化管中之半透膜為二氧化矽(silica)膜。All reagents were used in the QIAamp DNA Reagent Kit (Qiagen Taiwan Co. Ltd.), containing tissue lysate, cell lysate, cleaning solution I, cleaning solution II, rushing a liquid extracting protein and proteinase K, and a purification tube, wherein the semipermeable membrane in the purification tube is a silica membrane.
取約5x5mm大小的魚肝臟,置入2ml的螺蓋試管,加入800μl磷酸鹽緩衝液(phosphate buffer saline,PBS)以及一顆5mm鋼珠,以組織均質機均質化30秒。接著,加入800μl細胞溶解液,以振盪器混勻,再加入80μl蛋白質分解酶K,並使用振盪器混勻。於60℃下培育30分鐘使檢體溶解。之後,加入800μl的乙醇並以振盪器振盪30秒。於13000rpm下離心3分鐘,各取200μl上清液至四個樣品管中,分別為實施例1檢體、實施例2檢體、比較例1檢體及比較例2檢體。Fish liver of about 5x5mm size was taken, placed in a 2ml screw cap test tube, 800μl phosphate buffer saline (PBS) and a 5mm steel ball were added to homogenize the tissue homogenizer for 30 seconds. Next, 800 μl of the cell lysate was added, mixed with a shaker, and then 80 μl of proteolytic enzyme K was added and mixed using a shaker. The sample was incubated at 60 ° C for 30 minutes to dissolve the sample. Thereafter, 800 μl of ethanol was added and shaken with a shaker for 30 seconds. After centrifugation at 13,000 rpm for 3 minutes, 200 μl of the supernatant was taken into each of four sample tubes, which were the sample of Example 1, the sample of Example 2, the sample of Comparative Example 1, and the sample of Comparative Example 2.
實施例1Example 1
首先,先將純化管上頸部與一流體控制裝置氣密接合,純化管下尖部與一移液吸管氣密接合。First, the upper neck of the purification tube is hermetically joined to a fluid control device, and the lower tip of the purification tube is hermetically joined to a pipette.
結合步驟:拉動流體控制裝置的推桿,將實施例1樣品管中的實施例1檢體經由該移液吸管的吸取,由純化管的下尖部通過純化膜後,吸取至中間管體部,接著,將流體控制裝置推桿下推,排出未與純化膜結合的殘餘檢體,而核酸則電性結合於純化膜。Combining step: pulling the push rod of the fluid control device, the sample of the sample 1 in the sample tube of the first embodiment is sucked through the pipette, and the lower tip of the purification tube is passed through the purification membrane, and then sucked to the middle tube body. Next, the fluid control device pusher is pushed down to discharge the residual sample that is not combined with the purified membrane, and the nucleic acid is electrically coupled to the purified membrane.
清洗步驟:拉動流體控制裝置的推桿,將500μl清洗液I經由該移液吸管的吸取,由純化管的下尖部通過純化膜後,吸取至中間管體部,接著,將流體控制裝置推桿下推,排出該已清洗過純化膜的清洗液I。同樣的再一次進行清洗步驟,將750μl清洗液II由經由該移液吸管的吸取,由純化管的下尖部通過純化膜後,吸取至中間管體部,接著,將流體控制裝置推桿下推,排出該已清洗過純化膜的清洗液II。The cleaning step: pulling the push rod of the fluid control device, sucking 500 μl of the cleaning solution I through the pipette, passing the lower tip of the purification tube through the purification membrane, sucking it to the intermediate tube body, and then pushing the fluid control device The rod is pushed down to discharge the cleaning liquid I which has been cleaned of the purified membrane. Similarly, the cleaning step is performed again, and 750 μl of the cleaning solution II is sucked through the pipette, passed through the purification film by the lower tip of the purification tube, and then taken up to the intermediate tube body, and then the fluid control device is pushed under the rod. The cleaning liquid II that has been cleaned of the purified membrane is pushed out.
後清洗步驟:拉動流體控制裝置的推桿,將800μl的100%酒精經由該移液吸管的吸取,由純化管的下尖部通過純化膜後,吸取至中間 管體部,接著,將流體控制裝置推桿下推,排出該已清洗過純化膜的酒精;此步驟重複兩次。接著,將流體控制裝置抽吸並推排至少15次,使殘於在純化管內的酒精揮發。Post-cleaning step: Pull the plunger of the fluid control device, draw 800 μl of 100% alcohol through the pipette, pass the lower tip of the purification tube through the purification membrane, and then pipette it to the middle. The body portion, and then the fluid control device pusher is pushed down to discharge the alcohol that has been cleaned of the purified membrane; this step is repeated twice. Next, the fluid control device is aspirated and pushed at least 15 times to volatilize the alcohol remaining in the purification tube.
收集步驟:拉動流體控制裝置的推桿,將200μl沖提液經由該移液吸管的吸取,由純化管的下尖部通過純化膜後,吸取至中間管體部,並靜置3分鐘,接著,將流體控制裝置推桿下推,排出該溶有核酸的沖提液至1.5ml的微量離心管中。The collecting step: pulling the push rod of the fluid control device, sucking 200 μl of the extract liquid through the pipette, passing the lower tip of the purification tube through the purification membrane, sucking it to the middle tube body, and letting it stand for 3 minutes, then The fluid control device pusher is pushed down, and the nucleic acid-dissolved extract is discharged into a 1.5 ml microcentrifuge tube.
實施例2Example 2
實施例2的步驟與實施例1一樣,重複實施例1的步驟,僅將檢體換為實施例2檢體。The procedure of Example 2 was repeated as in Example 1, except that the procedure of Example 1 was repeated, and only the specimen was replaced with the specimen of Example 2.
比較例1Comparative example 1
依據QIAamp DNA試劑套組產品說明書,進行核酸萃取。結合步驟:利用微量分注器(pipette)將比較例1檢體吸取至純化管內,檢體係由純化管上方注入。接著,在純化管下方裝一廢液管,兩管件一起至離心機中於轉速13000rpm下離心2分鐘,殘餘檢體將通過純化膜而經由純化管下尖部的通道離心至廢液管中,離心完後,倒掉廢液管中的廢液,而核酸電性結合於純化膜上,純化管再套回廢液管中。Nucleic acid extraction was performed according to the QIAamp DNA Reagent Kit product data sheet. Binding step: The sample of Comparative Example 1 was pipetted into a purification tube using a pipette, and the test system was injected from above the purification tube. Next, a waste liquid tube is installed under the purification tube, and the two tubes are centrifuged in a centrifuge at a rotational speed of 13,000 rpm for 2 minutes, and the residual sample is centrifuged through the purification membrane to the waste liquid tube through the channel of the lower tip of the purification tube. After centrifugation, the waste liquid in the waste liquid tube is drained, and the nucleic acid is electrically coupled to the purified membrane, and the purification tube is placed back into the waste liquid tube.
清洗步驟:利用微量分注器將500μl清洗液I吸取至純化管內,清洗液I係由純化管上方注入。兩管件一起至離心機中於轉速13000rpm下離心1分鐘,清洗液I通過純化膜而經由純化管下尖部的通道離心至廢液管中,離心完後,倒掉廢液管中廢液,純化管再套回廢液管中。同樣的再一次進行清洗步驟,將750μl清洗液II吸取至純化管內,清洗液II係由純化管上 方注入。兩管件一起至離心機中13000rpm離心1min,清洗液II通過純化膜而經由純化管下尖部的通道離心至廢液管中,離心完後,倒掉廢液管中廢液,純化管再套回廢液管中。Washing step: 500 μl of the cleaning solution I is sucked into the purification tube by means of a micro-dispenser, and the cleaning solution I is injected from above the purification tube. The two tubes are centrifuged together in a centrifuge at a rotational speed of 13000 rpm for 1 minute. The cleaning solution I is centrifuged through the passage of the lower end of the purification tube to the waste liquid tube through the purification membrane. After the centrifugation, the waste liquid in the waste liquid tube is drained. The purification tube is then placed back into the waste tube. The same cleaning step is performed again, and 750 μl of the cleaning solution II is sucked into the purification tube, and the cleaning solution II is supplied from the purification tube. Square injection. The two tubes are centrifuged at 13,000 rpm for 1 min in a centrifuge, and the washing solution II is centrifuged through the passage of the lower end of the purification tube to the waste liquid tube through the purification membrane. After the centrifugation is completed, the waste liquid in the waste liquid tube is drained, and the purification tube is further set. Return to the waste pipe.
後清洗步驟:將兩套件於轉速13000rpm下離心額外的三分鐘以確保將清洗液完全移除。Post-washing step: Centrifuge the two kits at 13,000 rpm for an additional three minutes to ensure complete removal of the wash solution.
收集步驟:移除廢液管,並換上1.5ml的微量離心管套於純化管外。利用微量分注器將200μl沖提液吸取至純化管內,沖提液係由純化管上方注入至中間管體部,並靜置3分鐘,接著,將兩套件置入離心機中於轉速13000rpm下離心1分鐘以獲得該溶有核酸的沖提液至1.5ml的微量離心管中。Collection procedure: Remove the waste tube and replace it with a 1.5 ml microcentrifuge tube. Using a micro-dispenser, 200 μl of the extract was pipetted into a purification tube, and the extract was injected from the top of the purification tube to the middle tube body and allowed to stand for 3 minutes. Then, the two kits were placed in a centrifuge at a rotational speed of 13,000 rpm. Centrifuge for 1 minute to obtain the nucleic acid-dissolved extract into a 1.5 ml microcentrifuge tube.
比較例2Comparative example 2
比較例2的步驟與比較例1一樣,重複比較例1的步驟,僅將檢體換為實施例2檢體。The procedure of Comparative Example 2 was repeated in the same manner as in Comparative Example 1, except that the sample was replaced with the sample of Example 2.
以上實施例1、2以及比較例1及2的抽取出的gDNA之結果彙整於下表1中。The results of the extracted gDNA of the above Examples 1 and 2 and Comparative Examples 1 and 2 are summarized in Table 1 below.
由上表1可見,使用本創作的方法及裝置所抽取出的DNA濃度與使用習知方式所收取出的DNA濃度差不多,且方法較為簡便。As can be seen from the above Table 1, the DNA concentration extracted by the method and apparatus of the present invention is similar to the DNA concentration collected by the conventional method, and the method is relatively simple.
此外,本創作之方法及裝置可適用於不同廠牌的抽取核酸之純化管套組。In addition, the method and apparatus of the present invention can be applied to a purification tube set for extracting nucleic acids of different brands.
接著,為了比較使用親水性膜與疏水性膜對於本創作之方法的影響,且為了比較使用本創作之裝置與傳統離心方式的影響,進一步使用不同廠牌的半透膜並利用本創作之裝置以及使用傳統離心方式,進行核酸萃取試驗。Next, in order to compare the effects of using the hydrophilic film and the hydrophobic film on the method of the present creation, and in order to compare the effects of using the device of the present creation and the conventional centrifugal method, further use a semi-permeable membrane of different brands and utilize the device of the present creation. And nucleic acid extraction experiments were performed using conventional centrifugation.
實施例3Example 3
實施例3的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為PALL公司之一種親水性二氧化矽膜(品名:Glass Fiber Media),膜孔徑為1.0μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and the sample of Example 3 were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophilic cerium oxide film of PALL Corporation (product name: Glass Fiber Media), and the membrane pore diameter was 1.0 μm; The procedure of Example 1 was carried out in the apparatus of the present invention for nucleic acid extraction using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step was repeated twice.
實施例4Example 4
實施例4的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為PALL公司之親水性硝化纖維膜(品名:BioTrace),膜孔徑為0.2μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure of Example 4 was the same as that of Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophilic nitrocellulose membrane of PALL (product name: BioTrace), and the membrane pore diameter was 0.2 μm; The procedure was carried out in the apparatus of the present invention for nucleic acid extraction using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step was repeated twice.
實施例5Example 5
實施例5的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為Advantec公司之親水性硝化纖維膜(品名:Mixed Cellulose Esters),膜孔徑為0.2μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and the sample of Example 5 were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophilic nitrocellulose membrane (product name: Mixed Cellulose Esters) of Advantec Co., Ltd., and the membrane pore diameter was 0.2 μm; The procedure of 1 is to perform nucleic acid extraction in the apparatus of the present invention, using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step is repeated twice.
實施例6Example 6
實施例6的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為Advantec公司之親水性醋酸纖維素膜(品名:Cellulose Acetate),膜孔徑為0.45μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and the sample of Example 6 were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophilic cellulose acetate membrane (product name: Cellulose Acetate) of Advantec Co., Ltd., and the membrane pore diameter was 0.45 μm; The procedure of 1 is to perform nucleic acid extraction in the apparatus of the present invention, using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step is repeated twice.
比較例3Comparative example 3
比較例3的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例3所使用的半透膜。The procedure and the sample of Comparative Example 3 were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 3.
比較例4Comparative example 4
比較例4的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例4所使用的半透膜。The procedure and the sample of Comparative Example 4 were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 4.
比較例5Comparative Example 5
比較例5的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例5所使用的半透膜。The procedure and the sample of Comparative Example 5 were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 5.
比較例6Comparative Example 6
比較例6的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例6所使用的半透膜。The procedure and the sample of Comparative Example 6 were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 6.
以上實施例3至6以及比較例3至6的抽取出的gDNA之結果彙整於下表2中。The results of the extracted gDNA of the above Examples 3 to 6 and Comparative Examples 3 to 6 are summarized in Table 2 below.
由表2中可見,使用本創作之裝置所萃取出的核酸萃取量較習知技術為高,此係因使用本創作之裝置時,由於液體材料僅由純化管的下端進出,因此,在收集步驟中可重覆利用壓力裝置提供的正/負氣壓,使沖提液反覆通過半透膜,而增進核酸沖提的效率,而有效提升核酸的萃取量。相較於使用離心的方式,所有反應液體均是一次性地通過半透膜,而液體即被排除,使用本創作之方法及裝置可增進萃取量且提高萃取效率。It can be seen from Table 2 that the amount of nucleic acid extracted by the device of the present invention is higher than that of the prior art, because the liquid material is only used by the lower end of the purification tube when the device of the present invention is used, and therefore, In the step, the positive/negative pressure provided by the pressure device can be repeatedly used, so that the extract liquid can repeatedly pass through the semi-permeable membrane, thereby improving the efficiency of nucleic acid extraction and effectively increasing the extraction amount of the nucleic acid. Compared with the method of using centrifugation, all the reaction liquids pass through the semipermeable membrane at one time, and the liquid is eliminated, and the method and the device of the present invention can be used to increase the extraction amount and improve the extraction efficiency.
比較例7AComparative Example 7A
比較例7A的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為PALL公司之疏水性羧化聚偏二氟乙烯(品名:Fluoro Trans G),膜孔徑為0.2μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and sample of Comparative Example 7A were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with the hydrophobic carboxylated polyvinylidene fluoride (product name: Fluoro Trans G) of PALL Company, and the membrane pore diameter was 0.2 μm. The procedure of Example 1 was repeated, but the nucleic acid extraction was carried out in the apparatus of the present invention, using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step was repeated twice.
比較例8AComparative Example 8A
比較例8A的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為PALL公司之疏水性尼龍((品名:Hydrolon),膜孔徑為1.2μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負 氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and sample of Comparative Example 8A were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophobic nylon of PALL Co., Ltd. (product name: Hydrolon), and the membrane pore diameter was 1.2 μm; the procedure of Example 1 was repeated. , but in the device of this creation for nucleic acid extraction, the positive and negative The air pressure was 60 kPa / -60 kPa and the collection step was repeated twice.
比較例9AComparative Example 9A
比較例9A的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為PALL公司之疏水性聚醚碸(品名:Supor-450PR),膜孔徑為0.45μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and sample of Comparative Example 9A were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophobic polyether oxime (product name: Supor-450PR) of PALL Co., Ltd., and the membrane pore diameter was 0.45 μm; The procedure of 1 is to perform nucleic acid extraction in the apparatus of the present invention, using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step is repeated twice.
比較例10AComparative Example 10A
比較例10A的步驟與樣品皆同於實施例1,但將該純化管之半透膜置換為Advantec公司之疏水性聚四氟乙烯(品名:Supported PTFE),膜孔徑為0.45μm;重複實施例1的步驟,但係於本創作之裝置中進行核酸萃取,所使用的正負氣壓為60kpa/-60kpa,且收集步驟重複兩次。The procedure and sample of Comparative Example 10A were the same as in Example 1, except that the semipermeable membrane of the purification tube was replaced with a hydrophobic polytetrafluoroethylene (product name: Supported PTFE) of Advantec Co., Ltd., and the membrane pore diameter was 0.45 μm; The procedure of 1 is to perform nucleic acid extraction in the apparatus of the present invention, using a positive and negative gas pressure of 60 kPa/-60 kPa, and the collection step is repeated twice.
比較例7BComparative Example 7B
比較例7B的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例7A所使用的半透膜。The procedure and the sample of Comparative Example 7B were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 7A.
比較例8BComparative Example 8B
比較例8B的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例8A所使用的半透膜。The procedure and the sample of Comparative Example 8B were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 8A.
比較例9BComparative Example 9B
比較例9B的步驟及檢體均與比較例1相同,重複比較例1的步驟,僅將所使用的純化管中的半透膜置換為實施例9A所使用的半透膜。The procedure and the sample of Comparative Example 9B were the same as in Comparative Example 1, and the procedure of Comparative Example 1 was repeated, and only the semipermeable membrane used in the purification tube used was replaced with the semipermeable membrane used in Example 9A.
比較例10BComparative Example 10B
比較例10B的步驟及檢體均與比較例1相同,重複比較例1的 步驟,僅將所使用的純化管中的半透膜置換為實施例10A所使用的半透膜。The procedure and sample of Comparative Example 10B were the same as in Comparative Example 1, and the comparison of Comparative Example 1 was repeated. In the procedure, only the semipermeable membrane in the purification tube used was replaced with the semipermeable membrane used in Example 10A.
以上比較例7A至10A以及比較例7B至10B的抽取出的gDNA之結果彙整於下表3中。The results of the extracted gDNA of Comparative Examples 7A to 10A and Comparative Examples 7B to 10B above are summarized in Table 3 below.
由表3中可見,使用疏水性半透膜由於無法與核酸的親水性基團透過改變周圍的極性互相吸引,因此無論是使用本創作之方法及裝置,或是使用習知的管柱離心萃取法,均無法有良好的萃取效能。As can be seen from Table 3, the use of a hydrophobic semipermeable membrane is incapable of attracting the hydrophilicity of the nucleic acid to change the polarity of the surrounding, so whether using the method and apparatus of the present invention or using conventional column centrifugal extraction There is no good extraction efficiency.
綜上所述,本創作克服了技術偏見,不如習知技術中必須由純化管的上端加入檢體,而係在對該純化管提供具有核酸的檢體之前,便先將純化管一端(純化管上端)與壓力設備結合,而使萃取核酸時所須用到的所有液體材料均僅由純化管的另一端(純化管下端)進出。如此一來,使用本 創作之方法、裝置或自動化機台,於萃取核酸中的所有步驟均可簡易地利用提供正負壓力的方式,由純化管的同一端吸取/排出液體,不僅可簡化萃取步驟,且可使液體反覆通過半透膜而達到增進萃取效率的結果,且該自動化機台可不必配置離心機,僅須配置能夠提供壓力差的裝置,而可達到縮小體積的功效。In summary, this creation overcomes the technical bias. In the prior art, the sample must be added from the upper end of the purification tube, and the purification tube is first cleaned before the purification tube is provided with the sample having the nucleic acid. The upper end of the tube is combined with the pressure device so that all liquid material used to extract the nucleic acid is only in and out of the other end of the purification tube (lower end of the purification tube). In this way, use this The creation method, device or automated machine can easily use the method of providing positive and negative pressure in all steps of extracting nucleic acid, and the liquid is sucked/discharged from the same end of the purification tube, which not only simplifies the extraction step, but also allows the liquid to be repeated. The result of improving the extraction efficiency is achieved by the semi-permeable membrane, and the automated machine can eliminate the need to configure the centrifuge, and only needs to be equipped with a device capable of providing a pressure difference, thereby achieving the effect of reducing the volume.
20‧‧‧純化管20‧‧‧purification tube
201‧‧‧上頸部201‧‧‧ upper neck
202‧‧‧中間管體部202‧‧‧Intermediate body
203‧‧‧純化膜203‧‧‧Purified membrane
204‧‧‧下尖部204‧‧‧The tip
205‧‧‧蓋部205‧‧‧ 盖部
206‧‧‧O環206‧‧O ring
60‧‧‧壓力設備60‧‧‧pressure equipment
80‧‧‧移液吸管80‧‧‧ pipetting straw
802‧‧‧第一上部802‧‧‧ first upper
804‧‧‧中間部804‧‧‧ middle part
806‧‧‧吸取部806‧‧‧Drawing Department
808‧‧‧肋材808‧‧‧ ribs
90‧‧‧轉接頭90‧‧‧Adapter
901‧‧‧濾膜901‧‧‧ filter
902‧‧‧第三上部902‧‧‧ third upper
904‧‧‧第三長柱部904‧‧‧The third long column
906‧‧‧第三下部906‧‧ Third lower part
908‧‧‧刻紋908‧‧·grain
Claims (15)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103200029U TWM477925U (en) | 2014-01-02 | 2014-01-02 | Sample extraction device and kit |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TW103200029U TWM477925U (en) | 2014-01-02 | 2014-01-02 | Sample extraction device and kit |
Publications (1)
Publication Number | Publication Date |
---|---|
TWM477925U true TWM477925U (en) | 2014-05-11 |
Family
ID=51295320
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW103200029U TWM477925U (en) | 2014-01-02 | 2014-01-02 | Sample extraction device and kit |
Country Status (1)
Country | Link |
---|---|
TW (1) | TWM477925U (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI642679B (en) * | 2014-07-29 | 2018-12-01 | 精專生醫股份有限公司 | Device for purifying nucleic acid molecules and method using same |
TWI657851B (en) * | 2015-09-30 | 2019-05-01 | 精專生醫股份有限公司 | Machine for automatically extracting nucleic acid and syringe used with the same |
US12258555B2 (en) | 2018-11-09 | 2025-03-25 | Catchgene Co., Ltd. | Automated nucleic acid extraction device |
-
2014
- 2014-01-02 TW TW103200029U patent/TWM477925U/en not_active IP Right Cessation
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI642679B (en) * | 2014-07-29 | 2018-12-01 | 精專生醫股份有限公司 | Device for purifying nucleic acid molecules and method using same |
TWI657851B (en) * | 2015-09-30 | 2019-05-01 | 精專生醫股份有限公司 | Machine for automatically extracting nucleic acid and syringe used with the same |
US12258555B2 (en) | 2018-11-09 | 2025-03-25 | Catchgene Co., Ltd. | Automated nucleic acid extraction device |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW201412981A (en) | Method for extracting nucleic acid using air pressure and apparatus thereof | |
CN203663494U (en) | Sample extraction device, suction part thereof, fluid control device and containment set | |
TWI657851B (en) | Machine for automatically extracting nucleic acid and syringe used with the same | |
JP2008086893A (en) | Porous filter cartridge and its manufacturing method | |
WO2018181718A1 (en) | Nucleic acid separation apparatus | |
JP4025135B2 (en) | Nucleic acid separation and purification method | |
JP2008527973A (en) | Sample solution preparation method and sample solution preparation apparatus | |
TWM477925U (en) | Sample extraction device and kit | |
JP2005278437A (en) | System and method for automatically isolating/refining nucleic acid | |
CN205099665U (en) | Machine for automatic nucleic acid extraction and syringe used in conjunction with it | |
JP3890360B2 (en) | Nucleic acid separation and purification method | |
JP2004049107A (en) | Method for isolating and refining nucleic acid | |
CN210030647U (en) | Consumable and device for nucleic acid extraction | |
JP3635645B1 (en) | Nucleic acid extraction equipment | |
JP2005192558A (en) | Nucleic acid-adsorbing porous membrane for separating and purifying nucleic acid and apparatus for separating and purifying nucleic acid | |
CN219044930U (en) | Nucleic acid extraction device | |
JP2018171028A (en) | Nucleic acid separating apparatus | |
CN109797093A (en) | A kind of consumptive material, device and method for extracting nucleic acid for nucleic acid extraction | |
JP2005118007A (en) | Method for separation and purification of nucleic acid | |
CN115786078A (en) | Nucleic acid extraction device | |
JP2002345463A (en) | Nucleic acid-adsorption buffer and method for purifying nucleic acid | |
JP2016067291A (en) | Separation purification method of nucleic acid | |
JP2005137298A (en) | Method for separating and purifying nucleic acid | |
JP2005272397A (en) | Method for separating and purifying nucleic acid | |
JP2006136285A (en) | Method for separating and purifying nucleic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK4K | Expiration of patent term of a granted utility model |